GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NDT Pharmaceuticals Inc (OTCPK:NDTP) » Definitions » Shares Outstanding (EOP)

NDT Pharmaceuticals (NDT Pharmaceuticals) Shares Outstanding (EOP) : 0.04 Mil (As of Jun. 2008)


View and export this data going back to 2006. Start your Free Trial

What is NDT Pharmaceuticals Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. NDT Pharmaceuticals's shares outstanding for the quarter that ended in Jun. 2008 was 0.04 Mil.

NDT Pharmaceuticals's quarterly shares outstanding stayed the same from Mar. 2008 (0.04 Mil) to Jun. 2008 (0.04 Mil).

NDT Pharmaceuticals's annual shares outstanding increased from Dec. 2006 (0.03 Mil) to Dec. 2007 (0.04 Mil). It means NDT Pharmaceuticals issued new shares from Dec. 2006 to Dec. 2007 .


NDT Pharmaceuticals Shares Outstanding (EOP) Historical Data

The historical data trend for NDT Pharmaceuticals's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NDT Pharmaceuticals Shares Outstanding (EOP) Chart

NDT Pharmaceuticals Annual Data
Trend Dec05 Dec06 Dec07
Shares Outstanding (EOP)
0.01 0.03 0.04

NDT Pharmaceuticals Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.04 0.04 0.04 0.04

Competitive Comparison of NDT Pharmaceuticals's Shares Outstanding (EOP)

For the Biotechnology subindustry, NDT Pharmaceuticals's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NDT Pharmaceuticals's Shares Outstanding (EOP) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NDT Pharmaceuticals's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where NDT Pharmaceuticals's Shares Outstanding (EOP) falls into.



NDT Pharmaceuticals Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


NDT Pharmaceuticals  (OTCPK:NDTP) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


NDT Pharmaceuticals Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of NDT Pharmaceuticals's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


NDT Pharmaceuticals (NDT Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
7325 Oswego Road, Liverpool, NY, USA, 13090
NDT Pharmaceuticals Inc is a biotechnology company focused on developing revolutionary therapies for severe neurological disorders associated with traumatic brain injury. Its Nanoscale Particle Complex (NPC) technology represents the leading edge of phospholipid-based nano-encapsulation delivery systems (less than 100 nanometers in diameter; mean diameter of 40 nanometers in current liquid product samples with the capability to engineer significantly smaller nanocarrier particles) that create instant delivery of payloads into the bloodstream, beginning through the membranes of the mouth.
Executives
Francisco Kent Carasquero director, officer: Secretary 1057 EAST 21ST AVENUE, CANADA, VANCOUVER BC A1 V5V 1S6

NDT Pharmaceuticals (NDT Pharmaceuticals) Headlines

No Headlines